In particular, ABUS can be used to image small, node-negative cancers that are missed on mammography in women with dense breasts, he adds.Īttendees will also learn how this technology may provide detection of risky interval carcinoma. QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia ABUS in breast screening for asymptomatic dense breasted women whose. This technology can help radiologists improve decision-making, lessen fatigue, and enable better patient care for women with dense breasts, according to Namba. Namba tells AXIS Imaging News that his session is appropriate for breast-imaging team members who are interested in the significance and value of ultrasound imaging for women with dense breast tissue. The QVCAD innovative C-Thru technology combined. QVCAD is the next generation CAD system for automated breast ultrasound ('ABUS') based on deep learning algorithms.
Qview ge invenia software#
Namba will also discuss the diagnostic performance of QViewCAD, the FDA-approved system developed by Los Altos, Calif.-based QView Medical the software can be used with any currently installed GE Invenia system, according to QView Medical. LOS ALTOS, Calif.-(BUSINESS WIRE)-FDAPMA-QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia ABUS in breast screening for asymptomatic dense breasted women whose mammogram was negative. In addition to discussing the use of artificial intelligence alongside CAD technology, Namba will provide a review of published literature on CAD performance, insight into improving reading times, and a demonstration of CAD operating on ABUS cases. RSNA ’19 takes place in Chicago from December 1 to December 6.Ĭalled “AI Deep Learning Radiology in Reviewing ABUS Cases: Presented by GE Healthcare,” the session takes place Sunday, Dec. QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia ABUS in breast screening for asymptomatic dense breasted women. Radiologists looking for an introduction to artificial intelligence software for automated breast ultrasound screening (ABUS) case review at the Radiological Society of North America’s (RSNA) annual meeting should consider a session with Kiyoshi Namba, MD, executive advisor of the Hokuto Breast Center in Japan.
0 kommentar(er)
